Resultados de la búsqueda 351-360 of 14239 for Multiple sclerosis
The goals of the study are to prospectively evaluate clinical and laboratory biomarkers of multiple ... Immune Phenotyping in Amyotrophic Lateral Sclerosis.
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). ... Multiple Myeloma That Is Resistant To Current Standard Of ...
Inclusion Criteria are the following: age ≥ 18, blood cancer diagnosis (including B-ALL, multiple myeloma, and lymphoma), receiving a CAR-T product, able to ...
A Study to Evaluate Sex and Gender in Multiple System Atrophy ... Multiple System Atrophy (MSA) in order to ... Sclerosis (ALS). Advanced Care Planning in ...
This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and ...
This study is researching an experimental drug called linvoseltamab in combination with other drugs for the treatment of a blood cancer called multiple myeloma.
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...
... multiple myeloma. Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no ...
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). ... multiple myeloma, and lymphoma), receiving a CAR-T ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?